Home › Funds › ADAR1 Capital Management, LLC › GLUE

ADAR1 Capital Management, LLC position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

ADAR1 Capital Management, LLC reported holding 1,007,752 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.0M, representing 0.66% of its reported portfolio and ranking #39 among its reported holdings. ADAR1 Capital Management, LLC has disclosed GLUE holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.01M sh
Reported value held$12.02M
Portfolio Weight0.66%
First reportedQ3 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's GLUE position evolved

ADAR1 Capital Management, LLC first disclosed a stake in GLUE in Q3 2025 at 215,752 shares (US$1.6M). The position peaked in Q3 2026 at 1,007,752 shares, worth US$12.0M. Across 5 filings, ADAR1 Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,007,752 shares valued at US$12.0M — an increase of 791,000 shares quarter over quarter.. Notable position changes include a 365% increase in Q3 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 215.75K $1.60M New
Q4 2025 215.75K $3.38M Hold
Q1 2026 215.75K $3.55M Hold
Q2 2026 216.75K $5.25M Hold
Q3 2026 1.01M $12.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 59 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), Vestal Point Capital, LP (US$111.3M), BVF INC/IL (US$108.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held GLUE?

ADAR1 Capital Management, LLC has disclosed GLUE holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is ADAR1 Capital Management, LLC's current position in GLUE?

As of Q3 2026, ADAR1 Capital Management, LLC holds 1.01M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $12.02M, representing 0.66% of its reported portfolio and ranking #39.

Has ADAR1 Capital Management, LLC been buying or selling GLUE?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC increased its position in GLUE. The position peaked in Q3 2026 at 1.01M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, Vestal Point Capital, LP, BVF INC/IL, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.